Riki Goldbart
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
Papers in
-
- Hydrogels: synthesis, properties, applications 3
-
- Advanced Drug Delivery Systems 3
- Co-authors
- Joseph KostTamar TraitelLinShu LiuMarina WolfsonAharon AzaguryDalit Landesman‐MiloDan PeerMoshe Elkabets
- Journals
- Journal of Controlled Release (4 papers)Polymers for Advanced Technologies (3 papers)Pharmaceutical Research (2 papers)Bioengineering & Translational Medicine (2 papers)Israel Journal of Chemistry (1 paper)
- Partner nations
- IsraelUnited StatesRussia
In The Last Decade
Riki Goldbart
26 papers receiving 444 citations
Peers
Comparison fields: 5 of 82
- Pharmaceutical Science 77
- Biomaterials 147
- Molecular Medicine 55
- Biomedical Engineering 116
- Surfaces, Coatings and Films 17
Countries citing papers authored by Riki Goldbart
This map shows the geographic impact of Riki Goldbart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riki Goldbart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riki Goldbart more than expected).
Fields of papers citing papers by Riki Goldbart
This network shows the impact of papers produced by Riki Goldbart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riki Goldbart. The network helps show where Riki Goldbart may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Riki Goldbart, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 7 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 14 | |
| 10 | 2021 | 18 | |
| 11 | 2020 | 20 | |
| 12 | 2018 | 38 | |
| 13 | 2016 | 22 | |
| 14 | 2015 | 4 | |
| 15 | 2015 | 11 | |
| 16 | 2014 | 53 | |
| 17 | 2014 | 5 | |
| 18 | 2014 | 9 | |
| 19 | 2008 | 73 | |
| 20 | 1999 | 15 |
About Riki Goldbart
Riki Goldbart is a scholar working on Molecular Medicine, Pharmaceutical Science, Biomaterials, Genetics and Biotechnology, having authored 27 papers that have together received 458 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (12 papers), Advanced biosensing and bioanalysis techniques (7 papers), Ultrasound and Hyperthermia Applications (5 papers), Hydrogels: synthesis, properties, applications (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Advanced Drug Delivery Systems (3 papers), MicroRNA in disease regulation (2 papers) and Photoacoustic and Ultrasonic Imaging (2 papers). The work is most often cited by research in Pharmaceutical Science (77 citations), Biomaterials (147 citations), Molecular Medicine (55 citations), Biomedical Engineering (116 citations) and Surfaces, Coatings and Films (17 citations). Riki Goldbart has collaborated with scholars based in Israel, United States and Russia. Frequent co-authors include Joseph Kost, Tamar Traitel, LinShu Liu, Marina Wolfson, Aharon Azagury, Dalit Landesman‐Milo, Dan Peer, Moshe Elkabets, Moti Harats and Dror Avni. Their work appears in journals such as Journal of Controlled Release, Polymers for Advanced Technologies, Pharmaceutical Research, Bioengineering & Translational Medicine and Israel Journal of Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.